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effective, more resilient.
Not every relevant story will
make it into print. One story
about a student testifying
before Congress thanks to a
powerful Washington Post Op-Ed
won’t have happened by the
time we go to press. Another,
describing an exciting initiative that seeks to understand
and address inequities faced by
those with disabilities in athletics, the Sports Equity Lab, is still
on the drawing board. There are
more stories about our cultural
and intellectual diversity than
we have space to print; this
issue represents the very tip of
the iceberg.
Adrian Bonenberger
Editor, Yale Medicine Magazine
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dialogue

		Balancing
Yale School of Medicine
robert alpern is proud of the progress Yale School of Medicine (YSM) has
made in diversifying both the types of science and research pursued in New Haven,
and the people pursuing that science and research. Diversity is central to the mission
of scientific excellence and leadership at YSM, from diverse socioeconomic backgrounds to variety in intellectual and academic pursuits, to variation when
it comes to race, gender, creed, and nationality, YSM strives to be a national leader.
Yale Medicine Magazine sat down with Robert J. Alpern, MD, dean and Ensign
Professor of Medicine, to hear his thoughts on the subject, as well as why he favors
a strong commitment to ongoing diversification.
Given that Yale is one of the oldest and best medical schools in the United States, how has diversity played
a role in maintaining YSM’s competitive edge? Diversity in medicine and in biomedical research is criti-

cal to both fields. A diverse scientific and medical workforce understands and appreciates the needs
of a diverse patient population. In addition, patients frequently prefer physicians who are similar to
them, and thus understand their issues. We serve a broad range of patients and require the medical
and personal expertise needed to do so effectively.
How do we stack up against peer institutions in this department? Yale strives to be a leader, and we’ve
put significant effort into creating a diverse faculty, but we still have a long way to go. The diversity
of our faculty is increasing, but similar to other institutions, the higher you go in academic rank, the
less diversity there is.
Is there an active push to diversify the faculty and administrative leadership, or has the recent diversification
been the consequence of more qualified applicants—the pipeline beginning to deliver on its promise? There
has been a dedicated effort to identify and recruit outstanding faculty and administrative leadership
who also bring diversity to the medical school. The last two department chair hires, both of whom
are women, have been exceptional physicians and leaders; and the incoming dean, the first woman
at the School of Medicine to hold this position, is incredibly impressive. That still leaves us with 80%
of department chairs who are fairly homogeneous in the way that they have been traditionally. Even
today, women who want careers in medicine face more barriers in their careers as they move up the
ladder to become professors or department chairs. The pipeline is producing outstanding women and
minority faculty, but we need to be diligent in our efforts to identify them and develop their careers.
We’re living at a time when we are beginning to make progress.
It seems like every year, incoming classes of students are more diverse: economically, culturally, geographically, racially, and religiously. How has this changed since you were a medical student? When

I was a medical student there was some, but very little diversity in the medical school classes.
Women and underrepresented minorities were admitted to medical school but were few in number. Gender diversity has now been achieved with most medical school classes close to 50% women.
Underrepresented minorities remain underrepresented, but the numbers have improved. There
remains much work to be done.
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			Starting 2020
with an historic first
yale school of medicine is getting a new dean, and
for the first time in its 209-year history, she will be a
woman. Nancy J. Brown, MD, a graduate of Yale College
(where she majored in molecular biophysics & biochemistry) in the Class of 1981, comes to YSM from Vanderbilt
University. There, she is the Hugh Jackson Morgan
Professor and chair of the Department of Medicine. She is
expected to join Yale on February 1, 2020.
The latest in a long and storied
line of deans, Brown comes
to the position as successor to
Robert J. Alpern, MD, dean and
Ensign Professor of Medicine,
having already established a
standout reputation as an investigator, clinician, and leader.
“I am grateful to the search
advisory committee and President
Salovey for this opportunity,” said
Brown. “Dean Alpern has already
been very generous in ensuring
a smooth transition. I very much
look forward to meeting with
and learning from the members
of YSM and the broader Yale and
New Haven communities as we
chart our course.”
Alpern was enthusiastic
about the incoming dean, and
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the future of YSM. “Dr. Brown
has a record of outstanding
academic accomplishments
and leadership. I am confident
that she will have great success in furthering our efforts
in research, education, patient
care, and creating a diverse and
inclusive environment.”
The universal enthusiasm
on social media was clear as
colleagues and past trainees
chimed in with dozens of notes
of congratulations, noting
that Brown is also respected
as an inclusive and inspiring

mentor and colleague. From
the outpouring of responses
on Facebook, LinkedIn, and
Twitter, the following testimonials stood out:
“While we will miss her
extraordinary contributions, I
am excited for Nancy to assume
this leadership role and wish
her the very best on this exciting new stage in her career,”
tweeted Jeff Balser, MD, PhD,
dean of Vanderbilt University’s
medical school.
“Congratulations to Nancy,
who taught me a huge fraction of
what I know about clinical investigation & about hypertension,”
tweeted J. Brian Byrd, MD, MS,
from the University of Michigan.
“I have personally witnessed
Dr. Brown’s personal, deep, and
unwavering commitment to
trainees of all levels as a [member
of Vanderbilt University’s medical community]. I will be forever grateful for her leadership,
mentoring, and kindness. [YSM]
is very lucky!” tweeted Brian
Grieb, MD, PhD, chief resident
at Vanderbilt University Medical
Center’s Internal Medicine.
After finishing her studies at Yale, Brown graduated
from Harvard Medical School,
completed an internship and a
residency program at Vanderbilt
University, and has been a part
of its faculty ever since.
Brown’s specialty and
interests revolve around cardiovascular pharmacology,
pharmacogenomics, and using
drugs to understand pathophysiology. She has led National

Institutes of Health (NIH)funded research since 1993
and has defined the molecular
mechanisms by which drugs
for blood pressure and diabetes
affect kidney or cardiovascular disease. Brown commented
that the strength of discovery
and science at Yale, as well as
the opportunity to collaborate across campus, was one of
the attractions that led to her
return. Meanwhile, she remains
dedicated to providing care for
patients with resistant and secondary forms of hypertension.
The positive and immediate
public testimonials on Brown’s
behalf speak to another of her
passions: helping faculty, students, and trainees flourish in a
diverse and balanced work environment. Her sterling leadership
of Vanderbilt’s Department of
Medicine, which began in 2010,
corresponded with increases in
women and underrepresented
groups in medicine in faculty
and other positions of authority.
The team of doctors, staff, and
students assembled by Brown
has been remarkably effective.
Research funding was boosted
by 56%, including a 47% boost
in grant funding from NIH.
Citations increased, and people
working in her department were
more likely to be recognized by
national professional medical
organizations and associations.
Brown was recommended
to Yale University President
Peter Salovey, PhD, by a search
advisory committee chaired by
Lynn Cooley, PhD, dean of the

The incoming dean of
Yale School of Medicine,
Nancy Brown, MD, carries with her a strong
reputation as a leader,
researcher, and clinician.

Graduate School of Arts and
Sciences, who said of the committee’s work: “In 14 listening
sessions and numerous informal
meetings, they carefully collected feedback, suggestions,
and viewpoints about the current state and future of the
school.” President Salovey also
expressed gratitude for Alpern’s
longtime service and successful
efforts to strengthen Yale School
of Medicine’s research, clinical,
and educational potential.
—Adrian Bonenberger

»

A legacy of leadership
in hepatology

Among the many reasons the
VA Connecticut Healthcare
System in West Haven is
regarded as one of the best in
the country is its expertise in
treating liver disease. This legacy
extends back over decades and
is the result of many illustrious physicians and researchers
building on the work of their
predecessors. These same individuals are recognized for having played a role in developing
Yale School of Medicine’s reputation as a leader in the field.

Guadalupe Garcia-Tsao, MD,
chief of digestive diseases at
the VA Connecticut Healthcare
System; professor of medicine
(digestive diseases); and director
of the Clinical and Translational
Core of the Yale Liver Center,
highlights one aspect of the VA
CT’s success: the superlative
doctors and the longstanding
reciprocal relationship between
the Yale School of Medicine and
the VA. Another is the strong
history of liver research. “From
Gerald Klatskin, MD—a veteran himself—to Harold Conn,
MD, and Roberto Groszmann,
MD, there has been a legacy of
excellence here at the VA,” said
Garcia-Tsao.
Klatskin performed the
first liver biopsy at Yale in 1947.
Conn’s studies resulted in the
West Haven Criteria, a globally adopted grading system for
hepatic encephalopathy (altered
level of consciousness resulting
from liver failure). Groszmann
focused on cirrhosis and portal
hypertension. Each researcher’s
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Kathryn Nagel, MD,
has been using her
expertise and experience as a Yale School
of Medicine resident
with type 1 diabetes
to advocate for improved accessibility
to insulin.
For more on insulin, visit
ymm.yale.edu/insulin
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work overlapped and assisted
with those of the others. GarciaTsao led the VA CT Hepatitis C
Resource Center, one of four
centers nationally funded for
over 10 years for the treatment
and research of hepatitis C.
During this time, VA CT developed an enduring reputation
for excellence in liver education,
research, and innovations in
health care delivery.
James Boyer, MD, Ensign
Professor of Medicine (digestive
diseases), who founded the Yale
Liver Center in 1984 after his
mentor Klatskin retired, noted
that liver research at YSM and
the VA were for many years
inextricably intertwined. “For
many years, Dr. Klatskin would
give a talk every week at the
VA. It was where he’d buy the
Edgeworth tobacco he’d smoke
in his pipe, at the commissary,”
said Boyer. “Klatskin’s efforts
here and in West Haven laid the
groundwork, along with Conn
and Groszmann, for the work
we do today.”
Boyer remembers Klatskin
with great respect, and wrote a
compelling tribute to the man
who hired him into his laboratory—a speech published by the
American Gastroenterological
Association in the December 1983
issue of Gastroenterology on the
occasion of Klatskin’s receipt of
the Julius Friedenwald Medal.
That great legacy is carried on
by current faculty appointed primarily or exclusively to the VA.
Garcia-Tsao, who spends much
of her time tending to patients,

has many positive things to say
the service,” he said. It was good
about them as individuals and
that he came when he did; he
as a population. “Veterans are
was diagnosed with end-stage
incredibly generous as patients
liver disease in 2011. “They
and as research subjects,” said
told me in March of 2012 that it
Garcia-Tsao. “They are used to
was over if I didn’t get a transservice, and when offered oppor- plant, ‘say goodbye.’ ” Cochrane
tunities to participate in research, said. “Once I said I was onboard
veterans are almost always
with receiving a transplant and
excited to help.”
doing everything I needed to
Doctors enjoy the sense of
to make that happen, includpurpose derived from caring for
ing getting 100% sober, Dr.
veterans and from the benefits of Taddei moved heaven and earth
a nationwide health care system
for me.” Cochrane received a
focused entirely on caring for
transplant at the Mayo Clinic
this population. “The patients
in Jacksonville, Florida, in 2014.
here are extraordinary, and it’s
Taddei “fought to get me listed
a privilege to work for them,”
for a transplant,” Cochrane said,
said Tamar Taddei, MD, associ“I owe her my life.”
ate professor of medicine (digesSome wish to discontinue
tive diseases).
government funding for vetOne patient of Taddei’s,
erans’ health care under the
James Cochrane, credits her
assumption that private health
with saving his life. Discharged
care will better serve this popufrom the Navy in 1974 after a
lation. Taddei is unreservedly set
three-year stint, he waited until
against privatization initiatives
2010 to seek treatment. “A lot of
targeting the VA. Apart from
guys don’t think about the VA
the longer waits for “care in
when they’re getting out. All
the community”—two to three
they want to do is move on from
months, as opposed to 14–30
days in the VA—Taddei thinks
that providers who spend their
careers working with veterans
come to know more about efficient health care delivery for

V S H I V KOVA P H OTO

Liver research at Yale
was brought into the
modern era with a successful biopsy by Gerald
Klaskin, MD, in 1947.

this population than privatesector practitioners.
“Take hepatitis C,” Taddei
said. “The incidence of this
in the general population is
1.4%. But it’s as high as 12–20%
among veterans born between
1945–65, especially those who
served in Vietnam. The odds
are pretty slim of receiving better treatment anywhere else
than you can find here.” Recent
efforts to cure all veterans with
hepatitis C infection have met
with success, according to an
article posted on Military.com
by Patricia Kime on June 4, 2019.
Nearly 100,000 of the 126,000
veterans infected with hepatitis C have been cured to date.
Despite the great success in
curing hepatitis C, the prevalence of cirrhosis is increasing in
the VA, and VA CT is focused on
improving care of patients with
advanced liver disease. Patients
who suffer from cirrhosis are
at high risk of developing liver
cancer. VA CT is a regional center for liver cancer care, harnessing telehealth technology to
manage patients diagnosed with
hepatic cancer through a weekly
multidisciplinary liver tumor
board attended by providers
in Connecticut, Massachusetts,
Vermont, and Rhode Island.
“West Haven is great,” said
Cochrane. “Everyone there has
looked out for me from day one,
and I still see Dr. Taddei and her
team once every three months.
It’s a wonderful place. I don’t
know where I’d be without it.”
—Adrian Bonenberger

»

Social media use at
Yale School of Medicine
Social media has revolutionized
the way people communicate
and share information. The
information bottlenecks of old
print and broadcast media have
closed or had their influence
diminished, for better and for

knowledge and connect likeminded scientists and doctors to
one another while simultaneously
combatting misinformation.
Naftali Kaminski, MD, the
Boehringer Ingelheim Pharmaceuticals, Inc. Professor of Medicine
(pulmonary), (@KaminskiMed)
got into social media early, and
is a big believer in its utility.
“I’m usually an early adopter,”
he wrote via email, “I use
Twitter for medicine, research,
and activism. I use Facebook

Some YSM scientists and
physicians are very active
on social media, using
it to highlight their own
research and work, and
that of others. In spite
of its rough reputation,
Twitter has a surprisingly
robust and respectful
medical and scientific
community that actively
shares information.

worse, while a world of expertise and information lies at the
fingertips of individuals. The
new world is filled with people
connecting with each other,
from high school students like
climate activist Greta Thunberg
to protest movements in cities
the world over.
Many Yale School of Medicine
(YSM) faculty members have
accounts on social media. They
do their part to spread their

for family and my eclectic interests (music, cinema, art) and
sometimes activism.” Kaminski
has almost 3,000 Twitter followers, and posts frequently on
various issues throughout the
day. “For too long, physicians
and scientists have hidden from
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Offering medical
evaluations and
advice, Yale Center
for Asylum Medicine
helps asylum seekers
clear legal hurdles in
entering the country,
raising the odds of a
successful application
by almost 50%.
For more on asylum
seekers, visit
ymm.yale.edu/asylum
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the public eye,” he wrote. “It
is our responsibility to be present in the public domain, to
share our work, our values, and
our views.”
Another YSM faculty member who is active on social
media is Akiko Iwasaki, PhD,
the Waldemar Von Zedtwitz
Professor of Immunobiology,
professor of molecular, cellular and developmental biology, and of dermatology, and
a Howard Hughes Medical
Institute investigator. Iwasaki is
relatively new to Twitter—she
created her account there in
2017, and credits a former colleague, Kellie Jurado, PhD, with
helping to coach and mentor
her in good habits of use. Now
at over 11,000 followers, her
handle, @VirusesImmunity, is
considered highly influential
in her communities of virology and immunology, and she
has issued several tweets that
have, in contemporary parlance,
“gone viral.” She does not use
Facebook or LinkedIn frequently,
though she maintains accounts
there, preferring to focus on
Twitter engagements.
Howard Forman, MD, MBA,
professor of radiology and biomedical imaging and director of
the MD/MBA Program at Yale,
is another avid user of social
media. His experience is akin
to Kaminski’s; a self-described
early adopter, he joined Twitter
in 2008 but did not become
active on it until 2016 (his
handle, @thehowie, has over
11,000 followers). “Timewise,

I would say that Twitter is the
only account that I attend to
daily, for between five minutes
and two hours of my time,” he
wrote in an email.
Forman values Twitter for
helping him “hone my positions,” as well as giving him an
opportunity to evaluate viewpoints different from his own.
He said, “I have developed better
skills at expressing my opinions.
My skin is much thicker, both
on social media and in real life,
where I believe I take criticism
more easily, particularly when it
is offered in good faith.”
He cautions that social media
can be dangerous for young professionals. “I think you need to be
very wary,” he wrote. “Earlier in
one’s career, social media can be
risky. If you have direct patient
care responsibilities, you have to
choose between having a truly
public profile on social media or
one that is more anonymous.
If you choose to be public, which
I think is generally preferable,
you should consider how patients
might respond to you if you are
particularly aggressive in your
political stances.”
Iwasaki’s advice to faculty
interested in creating social
media accounts but unfamiliar
with the terrain is more optimistic. “Jump in!” she wrote. “Keep
in mind that these posts are read
by everyone. So, do be careful
about the content, and make sure
you are not inadvertently leaving
out some people or being hurtful
to others. The downside of social
media is that there are always

people who post negative or toxic
comments (trolls). The upside is
that you can reach thousands of
people with words of encouragement and support instantaneously. The pros far outweigh
the cons of being on social media.
You will reach an audience you
never thought possible!”
Other YSM faculty with
extensive followings on Twitter
include Harlan Krumholz,
MD, the Harold H. Hines, Jr.
Professor of Medicine (cardiology) and director of the Center
for Outcomes Research and
Evaluation (CORE), (@hmkyale)
who has over 15,000 followers
there; and Roy S. Herbst, MD,
PhD, the Ensign Professor of
Medicine (medical oncology) and
professor of pharmacology,
(@DrRoyHerbstYale) with over
2,500 followers. Some students
and residents have outsize followings on various social media
platforms. And many YSM alumni
are influential on social media,
with some accounts, such as Esther
Choo’s, MD ’01 (@choo_ek), boasting nearly 100 thousand followers.
Social media is entrenched
in most people’s personal lives,
and plays an increasing role
in how professionals talk with
each other. Many of YSM’s faculty, students, and alumni are
involved with the various platforms. Depending on whether
one prefers the advice of
Iwasaki or Forman, one might
decide to “jump in,” or hold
off until later in one’s career.
There’s no wrong answer.
—Adrian Bonenberger

a collection of recent
scientific findings

PROTEIN COULD BE KEY TO
UNLOCKING IMMUNE DISORDERS
Carrie L. Lucas, PhD, assistant professor of immunobiology,
led a team of researchers at Yale and at the National Institute of
Health in sequencing the genome of a 9-year-old girl with a
variety of unresolved health complications. Lucas and her colleagues discovered that the girl lacks a key protein—PI3Ky—which
also figures in certain types of cancer.

MEDICAID MISSES MARK ON MUSCULOSKELETAL CARE
Only four of Connecticut’s 29 orthopaedic-specific urgent care
centers accepted patients for treatment regardless of
the patient’s insurance type, according to a study by Yale
researchers, including Mary O’Connor, MD, director of YSM’s
Center for Musculoskeletal Care, Daniel H. Wiznia, MD,
assistant professor of orthopaedics and rehabilitation, and
Christopher A. Schneble, MD, a second-year resident.
This restrictive policy results in more patients looking
for treatment in emergency departments. “Cherry-picking
patients leads to systemic health care disparities,” said Wiznia.

STUDIES EXAMINE MENTAL HEALTH
AFTER NATURAL DISASTERS
A total of 160 studies were published between 1981 and 2001 on
the topic of psychiatric disorders in the wake of environmental
disaster, at the rate of eight per year. According to a recent
Yale School of Public Health study, in 2018, 178 articles were
published on the subject, many in Asia. As worries about climate
change increase, so too will research into what happens
to individuals and populations affected by such natural catastrophes as hurricanes, tornados, floods, earthquakes, or fires.

AI PREFERS OUTPATIENT TREATMENT FOR GI INFECTIONS
A form of automated intelligence (AI) may be better at distinguishing patients suffering from gastrointestinal difficulties who can safely receive treatment at home from those
requiring hospitalization, according to a recent study
led by Dennis Shung, MD. Researchers looked at six medical
centers around the world while creating their machinelearning model. In the future, it’s possible that this type of
program will enhance physicians’ diagnostic capabilities.
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DIVERSITY IS IN THE DNA OF SCIENCE. From such observers as Newton,
whose attempts to understand the physical world around him gave rise to a
world of testable hypotheses, to university researchers in the scientific revolution in every country and culture that has practiced it, scientists’ discoveries
are built upon conflicting information, different inputs, and varying perspectives. Countries and cultures that historically lacked a diverse approach to
science fared poorly compared to those with robust mechanisms for bringing
in different perspectives.
The evidence of this benefit both anecdotally and scientifically, is overwhelming. One well-known study published in 2014—“Collaborating With
People Like Me: Ethnic Co-authorship Within the U.S.”—drew on over 2.5 million research papers to determine that when scientists worked with people
from different areas and ethnic backgrounds, and sourced their research more
widely, the quality of their research was better. From a different vantage, a
study conducted in 2018 by the Boston Consulting Group demonstrated that
businesses with greater diversity across “gender, age, nation of origin (meaning employees born in a country other than the one in which the company is
headquartered), career path, industry background, and education” were 19%
more profitable than homogenous competitors.
Given this and other evidence that diversity goes hand in hand with better outcomes, the stories in this issue look at some of the ways in which Yale
School of Medicine has continued to emphasize diversity across its research
capabilities, curriculum, student body, faculty, and staff.
about the photographs

In an effort to visualize this diversity, Robert A. Lisak visited and photographed many familiar spaces
around the medical campus. Long camera exposures cause moving figures to blur and nearly detach
from the very traits that usually enable us to identify and categorize people, allowing viewers to focus
more on the work that happens across Yale School of Medicine.
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Examining distinction
Yale School of Medicine’s students and faculty are a
more varied group with each passing year, making for
a more balanced place to study medicine.
by adrian bonenberger

Yale School of Medicine’s first Black graduate was
Cortlandt Van Rensselaer Creed, MD ’57, who matriculated
in 1853. The son of a New Haven bootmaker, Creed overcame poverty and prejudice to serve as a surgeon with the
Union Army during the Civil War. He corresponded with
Frederick Douglass, and ran successful medical practices
in New Haven and Brooklyn. An energetic and accomplished member of New Haven’s society and medical community, Creed more than justified his admission to Yale.
According to the thesis of another far more recent
Black graduate, U.S. Navy Captain Daryl K. Daniels,
MD ’91, it took nearly 20 years for YSM to graduate its
second and third Black doctors, and 12 more before
it graduated its fourth. From then until 1960, when
Captain Daniels’ study stops, the school graduated
Black doctors sporadically and in small numbers. The
first Black woman to graduate from YSM, Beatrix
McCleary Hamburg, did not do so until 1948.
In the Civil Rights era, allowing and then facilitating equal access to medical education to all people
became a major priority for Yale. Thus began the process of creating a truly egalitarian learning experience;
one that is far closer to reality in theory and practice
today than at any time before.
“We put a lot of effort into making sure each class
is as balanced and diverse as possible given the pool of
applicants,” said Ayaska Fernando, director of admissions. “We are fortunate to have the luxury of drawing
on an incredibly diverse applicant pool, so each student
can uniquely add to the School of Medicine; holistically,
the class is strongest when those unique attributes are
complementary to each other and collectively demonstrate diversity across multiple fronts.”
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YSM is dedicated to the education of students, first
and foremost, and it’s unsurprising therefore that
diversification efforts started in earnest with scholars
matriculating at the institution. At the same time that
YSM and peer institutions were beginning to vary their
class compositions, they began efforts to do the same
with faculty. Those initiatives gathered speed in the
1970s and 80s.
When it comes to the diversification of faculty gender, several groups provided powerful advocacy over
the years. The first formal standing committees dedicated to the task were YSM’s Committee on the Status
of Women in Medicine or SWIM, which celebrated its
40th anniversary in 2019; and the Office for Women
in Medicine or OWM (also begun in the late 1970s and
the first such office in the United States). These groups
secured important advances for women specifically
and underrepresented minorities more broadly, especially in the last few years.
Nina Stachenfeld, PhD, senior research scientist
in obstetrics, gynecology, and reproductive sciences,
said “SWIM members as well as faculty and students
in other organizations have been lobbying for our constituents for years. We’re thrilled by recent wins, but a
lot of hard work remains to be done.”
When SWIM started out in 1979, said Stachenfeld,
the culture in medicine was aggressively patriarchal.
This unfair system was perpetuated by a lack of
women in leadership positions. And while female
students were admitted to elite medical schools
like YSM in more approximately equal numbers, that
did not translate into positions for senior faculty or
other leaders.

“What we’re talking about now, which we have
been talking about for some years, is how to fix ‘the
pipeline,’ ” Stachenfeld said. “This is the phenomenon
where one has parity with female and male medical
students, parity with junior faculty, and then, when it
comes to chairs and deans, not much parity at all. We
hope that status quo is changing.”
Other groups have organized to participate in driving parity beyond a balance between two genders;
the Faculty Advisory Committee (FAC) and Minority
Organization for Retention & Expansion (MORE) both
examine areas in which historical or present-day
minorities are underrepresented, and bring greater
attention to them. This work is coordinated by and run
through the Office of Diversity, Equity, and Inclusion.
The head of the office, Darin Latimore, MD, is deputy
dean and chief diversity officer.
“It said a lot about Yale School of Medicine that
they would create this role and empower it. Change
can be difficult, but change is necessary for growth,”
Latimore said.
Three of the many events that Latimore oversaw
in 2019 included: “Q-Med: Building LGBTQI+ Leaders
in Health Care,” held on March 30-31, believed to
among the first of its kind; the Respect Retreat held
on May 24, also believed to be the first of its kind at a
U.S. medical school; and a panel held on October 30,
“De-stigmatizing Disability: Tribulations and Triumphs
of Disability at Yale.” The Respect Retreat featured
Esther Choo, MPH, MD ’01, as well as the organization
she helped co-found, TIME’S UP Healthcare.
“Diversity and inclusion should be part of our everyday practices,” said Latimore. “My hope is that someday this office is obsolete, that people understand how
to respect each other and that our institution reflects
those fundamental personal values.”
“We talk about it, but do we do it? That’s the question I hope everyone is asking themselves,” said
Latimore. In the meantime, he plans to continue assisting the various allied groups and individuals on campus who are working to achieve equal representation.
/yale medicine magazine
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Adrian Bonenberger is editor of Yale Medicine Magazine.
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Discovery potluck
Laboratories and departments increasingly seek intellectual
and scientific breakthroughs through diversification.
by john curtis
Among the perks of working in the lab of Akiko
Iwasaki, PhD, are the potluck meals at weekly lab parties. The dishes, which range from Japanese sushi to
Korean barbecue to empanadas, reflect the diversity
of her lab team.
“Not only do they come from different racial and cultural backgrounds, but science backgrounds as well,”
said Iwasaki, the Waldemar Von Zedtwitz Professor of
Immunobiology and professor of molecular, cellular,
and developmental biology and of dermatology, and a
Howard Hughes Medical Institute investigator. “I have
medical doctors, biologists, and people who are working
in the computational side. When they get together, the
kinds of things they can achieve together is much more
than if I only have people of the same background.”
A case in point is the transgenic mouse Takehiro
Takahashi, MD, PhD, made. “I was expecting to have
some sort of phenotype related to autoimmune disease,” said Takahashi, who came to the lab two years
ago with clinical experience and a background in
neurology. “What I actually noticed was the gait—
they lose balance very easily. We never expected the
mice to have a neurological problem.”
And Takahashi’s training in neurology is why
Iwasaki celebrates the diversity of people from different fields working together. “There’s a lot of research
done over the decades that shows that diverse teams
produce more innovative discoveries in science,” she
said. “In order to have synergy between team members
you need to have diversity.”
That synergy has remained elusive in a university
setting. The Society for Experimental Biology and
Medicine was founded in 1903 to promote biomedical
research across disciplines. More than a century later,
in 2006, the society’s journal published this article,
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“The Future of Interdisciplinary Research and Training:
How to Conquer the Silo Guardians.”
Such barriers to cross-disciplinary diversity, said Gary
Brudvig, PhD, the Benjamin Silliman Professor of Chemistry
and professor of molecular biophysics and biochemistry,
are embedded within the structure of academia.
“The sciences are typically departmentally organized
and very siloed,” he said. “Chemistry is in one building and chemists see each other all the time, but they
never interact with other people unless there is some
reason to seek each other out. It’s not a very organic
process of creating interdisciplinary research, which is
becoming more and more important.”
About 15 years ago, Brudvig and colleagues created
an institute that brought together scientists from different fields who shared an interest in climate and energy.
The institute lasted about six years and was supplanted
when Yale bought the West Campus in 2007 and created the Energy Sciences Institute (ESI), which Brudvig
directs. “It created a very different environment,” he
said. “It’s focused on a topic, not a discipline.”
Faculty at the institute come from applied physics,
mechanical engineering, chemistry, and chemical and
environmental engineering. Researchers from such fields
as electrical engineering, geology and geophysics, and
molecular biophysics and biochemistry are present on the
institute’s advisory board.
The federal government, Brudvig noted, has encouraged interdisciplinary research over the last decade.
“Grants may be on a particular topic, but the scope
requires people with expertise in different areas,” he said.
At the ESI, the success of cross-disciplinary
research is reflected in its publications, written by
authors from different departments. And Brudvig
points to the serendipity that comes from proximity.
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Over lunch, he said, one of his postdocs chatted with a
scientist from a lab that needed help making molecules
to improve battery life. Brudvig’s postdoc knew how to
make those molecules.
“That collaboration got started without either principal investigator being aware of it, and it led to other
projects,” he said.
Bringing people together was the foremost goal of
All Points West, a half-day symposium organized by
graduate students this spring at Yale West Campus,
where institutes are arranged according to theme
rather than discipline.
“We wanted to get people across different disciplines
talking to each other,” said organizer Courtney Smith,
a fifth-year student in the Cancer Biology Institute.
“It’s easy to chat with people within your own institute,
but I hadn’t seen many events on campus aimed at
bringing the different institutes together.”
“On occasions when I did hear from other institutes,
it was normally at the faculty level,” said Becky LaCroix,

a seventh-year student at the Systems Biology Institute,
and co-organizer of the symposium. “This really felt like
a space for everyone to learn what’s going on.”
Students from each of the seven institutes plus the
Yale School of Nursing made five-minute research presentations at a level “scholars from all backgrounds
could understand,” Smith said. They also submitted
proposals for mini-grants to fund a year of research.
One of the three awarded was for a collaboration
between postdocs Eileen Condon from the School of
Nursing and Sylvie Estrela from the Microbial Sciences
Institute to look at how maternal stress might be
transmitted to a child via the gut microbiome.
LaCroix and Smith plan to repeat the symposium
next year. “We wanted to provide trainees with some
way to connect,” Smith said. “That is the goal of this
campus, to be collaborative.” /yale medicine magazine
John Curtis is a frequent contributor to Yale Medicine Magazine.
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A system optimized for success
Why homogeneity in the lab can hinder progress.
Change is a constant, and it takes a wide variety of responses to best meet it. Within
groups of people, diversity is the fertile ground from which fresh new ideas can spring.
“Homogeneity minimizes adaptability,” said John Dovidio, PhD, the Carl I. Hovland Professor of Psychology and professor in the Institute for Social and Policy Studies and of
epidemiology. “When you only have one way of doing something, you become a dinosaur. If conditions change—or if what you do well doesn’t have an audience or a group
of people that want it—it’s over.”
By contrast, Dovidio said, “There is a lot of research that shows that groups that
have more diversity are more creative; are more flexible; are more adaptable.” In diverse groups, the tensions that develop may be creative, forcing people to think more
complexly, he said. That can lead to more adaptability and more empathy, as members
must maintain a more nuanced worldview about everyone else in the group.
Ethnically diverse juries, for instance, think more deeply about the issues in trials
involving race than all-white juries do. Similar phenomena has been found in academic
organizations, industrial settings, and the legal system. There’s also evidence that
intercultural experience correlates with a higher level of creativity.
It’s true in science, too, said immunobiology professor Akiko Iwasaki, whose lab
includes researchers educated in China, Japan, and Korea. “I’m a strong believer in diversity, and I try to implement that in my own laboratory. Diverse teams produce more
innovative discoveries,” Iwasaki said. Indeed, scientific papers with a more diverse author lineup tend to include more references and to have a greater effect on their fields
than those with a more homogeneous group of authors.
There are undeniable downsides to maintaining a diverse group, however. “Socially,
it’s difficult to manage,” Dovidio said. “You have more social tension. You may have
some more, at least initially, misunderstandings. … Diversity requires some management and cultivation and attention that homogeneity doesn’t.” That management
could include encouraging people to think of themselves as members of the larger
group rather than of subgroups, while simultaneously taking care not to gloss over
important differences to create a “veneer of harmony,” he said.
For example, we can “get people to say that we are connected in a positive way with
one another—we are Americans—but that we come in different flavors.” It can be difficult
for groups to navigate that kind of discomfort. But a rich reward often awaits those that
succeed. “The benefits of diversity are not simply about helping minorities,” Dovidio said.
Rather, diversity “is also about helping majority group members—helping people who
identify with the whole system—to be much better, more complex, more flexible.”
—Jenny Blair, MD ’04
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Inclusion of women
as a diversity measure
The changing ways in which women have been
included and studied at Yale School of Medicine over
the years is a useful gauge of progress.
by carolyn m. mazure, phd
When we think of diversity at an academic medical
center, our focus tends toward reviewing the composition of our faculty, students, and staff, and ensuring that
our academic community is broadly representative of
our population at large. In addition to inclusion of “the
many” being the right thing to do, diversity fosters a
more creative and productive working environment.
To build diversity within our school, one goal has
been to increase the number of faculty members who
are women; and over many years, the school has considered how to make the environment more welcoming
to women and supportive of their academic careers.
In 1988, for example, Dean Leon Rosenberg, MD,
HS ’63, formed a task force to design a plan for increasing the number of women at all faculty levels. The task
force report indicates that as of 1988, “Many people in
academia assume that discrimination against women
has ended, since there has been a significant increase
in the number of women students, house staff, and
junior faculty in recent years.” As evidence of this at
YSM, 1988 data are provided to show that 33% of our
entering class of medical students were women. Yet, as
this thoughtful report also points out, “women occupy
only 7% of the total tenured faculty of 254 …,” and the
change in the number of women entering the medical
community has been due “in part to the enactment
of anti-discrimination legislation in 1964.” The report
concludes that women remain underrepresented, and
identifies a “perception bias” about how women perform as faculty that holds back their full inclusion.
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There is much more to this careful report and numerous subsequent reports, such as the 1994 Report of the
Dean’s Task Force on Senior Women in the School of
Medicine constituted by Dean Gerard Burrow, MD ’58,
HS ’66; the 2003 Report from the Commission on
Women Faculty, requested by Dean David Kessler, MD;
the 2015 Ad Hoc Task Force on Gender Equity, and
others focusing on various aspects of gender equity.
Each has marked renewed effort in advancing the metrics of change, and these metrics now show that over
half of our entering medical school class are women and
a quarter of tenured faculty are women.
However, these more recent metrics do not obscure
the significant challenges that remain. And here we
turn to a common thread initially reported by the 1988
task force and reflected across subsequent reports. This
thread is the notion of a perception bias about women,
a bias which must be countered by gathering objective
data that show the many and varied contributions of
women faculty.
This struggle for inclusion of women extends to
whom we study and for whom we develop our treatments and prevention strategies. In research, there has
been a perception bias about the need to study women.
It was not until the 1993 NIH Revitalization Act
was implemented that the National Institutes of
Health required that women be included as study
participants in NIH-funded studies. Prior to that time,
the prevailing tradition was not to include women in
clinical trials or analyze data by sex or gender, leaving

an enormous gap in our knowledge about the health
of women.
Of the three main reasons for excluding women,
one revolved around the commitment to protect
women from experimental risk that could adversely
affect childbearing. Though an important goal, this
restriction for inclusion as a study participant became
broadly applied to women. The Institute of Medicine’s
study on ethical and legal issues on the inclusion
of women found that protectionist policies did not
account for all inattention to the study of women’s
health and concluded that inattention also arises from
biases that permeate society and science. The second reason women were generally not included was
predicated on the misinformation that women are less
affected by many health conditions and, if affected,
syndromes and responses are the same across genders.
Finally, women were often not included due to the
“complexity” that hormonal variation brought to a scientific study. Yet, this raises the question—doesn’t this
variation, as well as other sex-specific factors, actually
require the study of both women and men? To be sure,
some studies included women if a condition is unique
to women, such as reproductive cancers, or if a condition is highly prevalent in women, such as depression.
However, in these latter studies, data were not analyzed for sex or gender differences, again leaving an
important knowledge gap for women and men.
Women’s Health Research at Yale (WHRY) was
founded in 1998 to ensure a leadership role at YSM in
remediating these gaps—knowing that, as indicated by
the American College of Physicians, women are more
likely to suffer from chronic diseases and disability as
well as acute and chronic pain, die following a heart
attack, develop depression and anxiety, have autoimmune diseases, and develop Alzheimer’s disease.
Since its inception, WHRY’s goals have been to
ensure women’s lives are advanced through research
and its clinical translation; share new findings with
the public to inform personal health decisions; and
promote the study of difference between and among
women and men to enhance the well-being of all.
Moreover, WHRY’s goals include setting the stage for
important discovery in basic science by always including females in studies using vertebrate model systems,

as now required by the NIH. With these goals in mind,
WHRY has initiated new studies and research collaborations, and funded over 100 faculty projects from
19 YSM departments, sparking innovation and productivity in uncovering new findings on pressing health
concerns for women ranging from cancers to cardiovascular disease.
For example, WHRY-affiliated Yale investigators
have uncovered metabolic and signaling pathways for
a colon cancer prevalent in women, differential effects
of stress on neurodevelopment in adolescent girls and
boys, a new treatment for autism in girls, an innovative therapeutic “prime-and-pull” vaccination strategy
to prevent sexually transmitted infections and cervical
cancer, and a more effective taxonomy for identifying
acute myocardial infarction in women—among many
other useful and meaningful discoveries. Importantly,
our funded investigators subsequently have generated
over $100 million of new research grants to pursue the
research they have launched with WHRY support.
Maintaining the trajectory of progress in studying
women and sex/gender differences requires believing there is value in diversity and retiring the notion
that difference means better or worse. The metrics of
diversity are important in assessing our progress, but
fundamentally diversity is about perspective. Teaching
the next generation of investigators and clinicians
about the value of diversity and modeling inclusiveness
is what will secure progress for human health and our
scientific future. /yale medicine magazine
Carolyn Mazure is the director of Women’s Health Research at Yale.
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When one career
isn’t enough
Most people attend medical school to become physicians;
some, however, use their degrees to pursue other goals.
by alison mosier-mills

For some MDs, a commitment to medicine extends
beyond the exam room or the lab bench. “I often
advise students that the first career they choose isn’t
necessarily what they’re going to be doing forever,”
said Lisa Ide, MD ’89, MPH, the chief medical officer
of Zipnosis, a virtual health care technology company.
This mindset might not surprise millennials, who are
increasingly likely to anticipate having a series of different careers rather than a single lifelong one. For
most medical students, though, the standard postgraduate path is residency followed by academia or clinical
practice. Some alumni of the Yale School of Medicine,
however, have managed to use their MDs in unorthodox ways.
“I’m struck by the zigs and zags,” Rob Kolodner,
MD ’74, vice president and chief medical officer of the
telehealth company ViTel Net, said of his own journey
after medical school. Neither Ide nor Kolodner, both of
whom appeared on an alumni panel on career transitions in June, intended to pursue the work they ended
up choosing. Ide recalls a pivotal moment during an
overnight shift in the emergency department, when
her patient—a mother with a young son in tow—waited
hours to receive treatment for an uncomplicated ear
infection. Ide’s frustration with clinical inefficiency
shifted her focus from individual patient care to
improving population-wide access to health care. She
pursued an MPH degree and a second residency in
occupational health, which equipped her for employee
health leadership positions at General Mills and
Fairview Health Services.
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Yet another pivot brought her management expertise back to the problems she’d encountered in the
emergency department: at Zipnosis, she and her team
of software engineers strategize ways to streamline
care delivery. “I love coming to work, knowing that
my job is to prevent that mom and her son from sitting
in the ED.”
Kolodner was also drawn to data that improve
patient care and came to medicine with a basic
understanding of computer programming. During his
residency in the 1970s, he was one of the few psychiatrists who used a computer to manage research references. “Looking at this data made me realize that there
was an awful lot coming out of the literature that the
practitioner wasn’t using.” He accepted a position as
the director of medical information resource management at the Department of Veterans Affairs (VA), and
proposed providing each VA hospital with a computer.
Despite initial bureaucratic pushback, Kolodner’s team
implemented the world’s first large-scale electronic
health system. As the national coordinator for health
information technology, he continued advocating for
health information systems. At ViTel Net, he now uses
technology to empower individuals to control their
own health care.
Connecting people from different disciplines has
been a defining component of each role he’s occupied.
“The type of innovating I do is combining existing things
in new and exciting ways. It requires adaptability.”
The flexibility of Yale’s curriculum may prepare
alumni for unconventional occupations, and for the
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uncertainty that comes along with them. “The Yale
system taught me how to learn and keep learning,” Ide
said. “With each pivot, I felt comfortable jumping in
and developing new skills.”
Alumni like Ide and Kolodner trained for their
nonmedical pursuits on the job, but other students
seek dual degrees in preparation for unconventional
paths. Yale offers a number of joint degree programs in
areas like policy, law, business, history, forestry, and
theology, among others. Barbara Kazmierczak, MD,
PhD, the director of Yale’s MD-PhD program, said that
students pursuing nontraditional scholarship bring
distinctive insights and goals. “Compared to other
physician-scientists we’re training, these students
are often drawn more explicitly to shaping the way in
which medicine is practiced or perceived.”
Marco Ramos, MD ’18, PhD ’16, pursued a PhD in
history of science and medicine alongside his medical training. His historical research, which focuses on
health activism in the Global South, was informed by
his clinical interests in psychiatry. His own engagement with social justice in medicine is bolstered by
rigorous historical evidence. “It was an opportunity
to deliberately blur the lines between the sciences,
humanities, clinical work, and political action.”

While YSM offers and encourages interdisciplinary
pursuits, it also emphasizes clinical leadership. “It makes
a difference when health companies have a practicing
physician on their team,” said Ide. “They understand
what it’s actually like to be responsible for a whole panel
of patients or struggle with electronic medical records.”
Howard Forman, MD, MBA, the director of Yale’s MD/
MBA program, said that the joint degree prepares students to work in a variety of fields—its graduates are leaders in politics, technology, and global health—but, only
three students in the program’s 20-year history have
opted out of matching into a residency. He’s proud of
these numbers—in peer programs, the proportion of students leaving medicine is closer to one-third or one-half.
Preparing for an unconventional trajectory implies
a willingness to pursue interdisciplinary work.
Kolodner suspects that these alums will be surprised
by their paths. “They’re laying a rich foundation and
acquiring skills earlier on, but they’ll likely follow
the same zigs and zags, the unanticipated things that
push us in different and exciting directions.” /yale
medicine magazine
Alison Mosier-Mills is a first-time contributor to Yale Medicine Magazine.
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Balancing the curriculum
Yale School of Medicine administrators, faculty, and students work together to make sure the school’s academic
offerings minimize potentially harmful distractions.
by john curtis

For most of its history, the School of Medicine was
a place where young white men learned from older
white men. Those days are gone. Black men and women
trickled into the medical school in the middle of the
20th century. By the 1990s, women made up half of
each medical school class and the presence of minority
students was increasing.
Still, attitudes, biases, and stereotypes have lingered
in the curriculum. Across the country, medical schools
are recognizing that lab tests and vital signs don’t tell
the whole story; and that to provide the best care, doctors must understand how race, gender, sexual orientation, poverty, and access to health care affect their
patients’ health—as well as their own inherent biases.
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This concern is not just academic. Knowing about
patients’ lives has consequences for their care. “If we
are ever going to get to the point of closing health care
disparities, physicians of tomorrow must have a much
better understanding of the people they are treating,”
said Darin Latimore, MD, deputy dean for diversity
and inclusion.
A fourth-year MD-PhD student on the Committee
for Diversity, Inclusion, and Social Justice put it more
forcefully. “People are dying and suffering due to
lack of appropriate care that can stem from providers’ biases and false or inaccurate information from
their medical training, like race-based medicine,” said
Sahana Kribakaran.
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For years, students have been advocating for a
curriculum that recognizes the importance of social
determinants of health. Their efforts bore fruit at
a town hall in November 2015 with Dean Robert J.
Alpern, MD, Ensign Professor of Medicine, when led
by the organization NextYSM, students voiced their
concerns. In addition to changes in the curriculum,
they highlighted the need for more support for minority students, more minority faculty, reporting on bias
incidents, and recruitment of a diversity officer.
The Dean’s Committee for Diversity, Inclusion, and
Social Justice was created as a result, and the school’s
Educational Policy and Curriculum Committee (EPCC)
began looking into the curriculum. In March 2018,
an EPCC subcommittee recommended enhancing
opportunities for health equity research, creating a
certificate in health justice, promoting professional
development, establishing a social mission statement,
and showing a commitment to faculty diversity. Two
key elements of the plan were weaving a health equity
thread throughout all four years of medical school and
creating a requirement for community service.
The subcommittee, chaired by Marcella NuñezSmith, MD, MHS ’06, associate professor of medicine
(general medicine), and of epidemiology (chronic
diseases), and director of the Equity Research and
Innovation Center, interviewed students, faculty, and
representatives of community-based organizations.
“We reviewed the curriculum to see how it covered
issues of social determinants of health, not only in
terms of where they are covered, but the quality of
that coverage,” said student and committee member
Ram Sundaresh. “There were some areas where it
was covered adequately, but we identified a lot of areas
for improvement.”
“The concept of race in the curriculum and clinical
care is raised all the time, but we don’t really teach it
in a rigorous way,” said Nientara Anderson, a fourthyear medical student on the committee. “Race-related
terms aren’t talked about in ways that are up to speed
with current scholarship.”
Anderson said it’s not just a matter of how patients
are treated. People of color and varying sexual identities and orientations are present in today’s classrooms.
“Every time these issues are treated in an ignorant,

incorrect, insensitive, discriminatory, or biased way,
there are people in the classroom experiencing discomfort, alienation of professional identity, a sense
of not belonging in the classroom, a sense of being
singled out or insulted by the way things are being
taught,” said Anderson.
Both the diversity thread and community engagement are works in progress. The medical school has hired
a community-based experiential learning coordinator
and is interviewing for the post of equity thread leader.
The school is coordinating with community groups and
neighboring universities whose students are also engaged
in health projects in New Haven.
“Students from many colleges and universities volunteer in the greater New Haven community. It is unrealistic for us to assume that a local nonprofit would know
which projects are best suited for an undergraduate versus a pharmacy student or medical student, for example.
Part of our task is to create an effective method of
pairing our students with community agencies that
will benefit from the unique skills and knowledge that
medical students bring to the table.”
Latimore said that while the school is in the early
stages of “figuring out what the curriculum should
look like,” the goals are clear.
“When a student takes a history, if they ask, ‘Do you
have food hunger?’ and they hear ‘yes,’ I want them
to say, ‘Here are agencies that can help you,’ ” he said.
“If the students only learn that African Americans
experience certain diseases at a higher rate, or that
the LGBTQ community faces certain diseases at a specific rate, but do not ask the deeper questions about
the patient’s ‘lived experiences,’ we will not have met
the mark. We hope that our students will leave with a
curiosity about and understanding of the complexity of
the individual sitting before them, with the humility
to learn, and with a knowledge of the resources that
they can offer that person.” /yale medicine magazine
John Curtis is a frequent contributor to Yale Medicine Magazine.
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Gaming the system
A board game to ease the stress of learning organic chemistry.
by adrian bonenberger
Most students hoping to enter medical school view organic
chemistry, colloquially called “orgo,” with apprehension
and fear; failure to excel in the course means risking one’s
chances of admission to a good institution. Failure to pass
the course means dooming one’s dreams of becoming a
doctor entirely.
Prerak Juthani, however, a third-year student at Yale
School of Medicine, loved his time in organic chemistry.
He saw it as a game in which you had to use different
chemicals to synthesize unique substances.
“I enjoyed that class, but I understand why people
struggle,” said Juthani. While he is aware of the course’s
dire reputation, he believes that the problem is not
with the material so much as the context surrounding
the course, and existing pedagogical approaches to it.
“Organic chemistry is a very unusual class in the sciences,
and people have to study for it differently, which throws
them for a curve.”
That’s why Juthani co-founded REACT! with a
University of California, Berkeley undergraduate while he
was there. REACT! takes study aid to a whole new level,
combining attributes of board games with attributes of
a card game, all dedicated to helping students master
organic chemistry.
“Because of my passion for it, I began to tutor struggling students, and in the process figured that I could turn
the concepts of organic chemistry into a study aid,” said
Juthani. “I got together with a couple friends, and the
more we talked about it, the more we realized orgo could
be gamified—turned into a competitive game.”
According to statista.com, a website dedicated to
aggregating and analyzing market data, the global
board game industry in 2019 is worth approximately
$8.5 billion. That makes a study aid that’s pitched
in a board game format a good bet financially—and
an excellent fit for the intellectually stimulated
high-achieving undergraduates who must take the
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daunting class in order to matriculate at medical or
graduate school.
After raising money through a Kickstarter campaign—
over $15,000—the team was ready to take it live. Now,
REACT! is available at $40 per set. The game, played by two
to four people, includes 212 cards, four reaction maps, four
“lab benches,” four dry-erase markers, and one manual.
“The goal is to score as many points as possible,” said
Juthani. “You can score many points by saving up and
making one big compound, or score a few points many
times with smaller reactions. That’s the element of strategy in the game, knowing what’s out there and seeing a
viable path based on the reagent cards in your hand.”
According to the co-president of REACT!, Daniel
Rosenthal, helping people learn science comes naturally
to Juthani. “We met in 2015, a year before Prerak started
REACT! He was an energetic student-leader, tutoring
hundreds of UC Berkeley students in biology and chemistry at UC Berkeley’s Student Learning Center.”
Rosenthal believes great things are in store for REACT!,
and also for his colleague: “Prerak is dynamic, driven,
and innovative. Now that he’s at Yale School of Medicine,
he’s encouraging me to guide our team and take REACT!
to new heights.”
For Juthani’s part, he’s excited about ways to connect
with people in and provide value to the New Haven community. Though it took a little while to adjust from his
native San Francisco, Juthani said YSM feels like home.
“There are so many things happening here at Yale School
of Medicine, it can be overwhelming. But once I had spent
a couple months here, I found my people and have been
able to create a community that drives me to continually
do bigger and better things. I’m hoping to continue pursuing my passion of entrepreneurship by doing an MBA
here in the near future.” /yale medicine magazine
Adrian Bonenberger is Editor of Yale Medicine Magazine.
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A complex but enduring
partnership
After two centuries of shared history, the School of Medicine
and the city of New Haven continue to shape each other.
by rebecca j. frey, phd

’99

Yale School of Medicine (YSM) in the 21st century is
rightly considered a world-class institution, while
the city that surrounds it is equally renowned for
the excellence of its hospitals and biotechnology companies. Today, the relationship between YSM and
New Haven is strong, but it wasn’t always that way:
the pair has weathered setbacks in their growth and
their relationship.
YSM was founded during a period in which professional schools in law, medicine, and theology separated
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from undergraduate colleges. The Medical Institution of
Yale College, as it was then known, was not chartered
until 1810. Its beginnings in a building on Prospect
Street soon brought it into conflict with the townsfolk,
then numbering fewer than 7,000 souls. A riot broke
out in 1824 when the body of a young woman taken
from the cemetery was discovered in the cellar of the
Medical Institution. While New Haveners held general
medical practice in high regard, dissection associated
with grave robbing was taboo.
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The Industrial Revolution brought many changes
to city and school alike, not all of them positive. New
Haven’s 1830s investment in building a canal northward
to Northampton squandered capital that could have
been used to build a railroad. On the other hand, Eli
Whitney’s cotton gin and gun factory brought prosperity to the city and turned it into a manufacturing center
for military equipment. As a result, New Haven’s population grew from 20,000 in 1850 to 40,000 only 10 years
later. The medical school made its own history in this
period by graduating its first African American student
in 1857 and by moving to York Street in 1860. It became
the official medical school of the university in 1887.
YSM’s stature declined after the 1890s, however.
Abraham Flexner noted in his famous 1910 report
on American medical education that although Yale
compared favorably to medical schools that were not
university-affiliated, its departments of anatomy, bacteriology, and pathology were deficient; its professors
had to do routine work rather than research because
they lacked assistants; and the study of obstetrics and
gynecology was limited to the outpatient clinic in the
hospital. World War I brought two important innovations: the establishment of the Department of Public
Health (later to become a separate school) in 1915, and
the admission of the first women students in 1916.
But the school’s four buildings were scattered across
downtown New Haven, and it had to rely on the university to cover its debts.
It was Milton Winternitz, MD, who transformed YSM
from the university’s stepchild to a national leader in
medical education. Winternitz, dean from 1920 to 1935,
not only raised money to give the school financial stability, but also supervised its move to its present location
next to what is now Yale New Haven Hospital. He added
the Department of Psychiatry and the School of Nursing
as well as recruited a stellar faculty that brought YSM
into the front rank of American medical schools. Most
importantly, he introduced the Yale system, an approach
unique to YSM that deemphasizes grades and class ranking, and encourages medical students to become flexible
and independent thinkers (as their varied postgraduate
careers demonstrate). Winternitz’s requirement of a thesis for the MD degree is one reason why a high number of
YSM graduates still enter academic medicine.

The 1950s witnessed the impact of the automobile
and the construction of interstate highways on both
the city and its medical school. As the city’s population grew to a postwar high of 160,000 and its medical
center attracted increasing traffic, Mayor Richard C.
Lee decided in 1957 to tear down a Jewish, Irish, and
Italian immigrant neighborhood near the hospital to
make room for an expressway and two frontage roads.
In addition to destroying one of New Haven’s most
distinctive areas, the Oak Street Connector severed
the medical center from the rest of the university and
introduced numerous hazards for drivers and pedestrians alike. Downtown Crossing, a three-phase project to redesign the expressway is currently in Phase
2. Completion is scheduled in 2021. Planners hope it
makes New Haven friendlier to people commuting
by foot—after all, the city has a higher percentage of
residents who walk to work than any other city in
New England.
YSM contributes to the revitalization of downtown
New Haven in several ways—first, by ensuring that
all its new buildings meet Leadership in Energy and
Environmental Design (LEED) certification standards.
Second, the school is working with the city to make
the medical campus more pedestrian-friendly. Most
importantly, however, YSM is deeply involved with
the surrounding community to meet its most pressing health care needs. Faculty and students provide
care for people in a wide range of settings, from YSM’s
refugee clinic for adults and the student-run HAVEN
Free Clinic in Fair Haven to the Neighborhood Health
Project (which provides free diabetes and blood pressure screenings) and an expanded addiction medicine
program. While many challenges remain in regard to
human need as well as urban infrastructure, YSM and
New Haven are committed to meet them as partners.
/yale medicine magazine
Rebecca Frey is a contributor to Yale Medicine Magazine.

Autumn 2019 35

R O B E R T A . L I S A K P H OTO

A disease deflector
Microbial biodiversity helps keep humans healthy by shielding
them from fatal infections.
by jenny blair, md ’04

The outside world teems with microscopic objects.
Many of these busy microbes invade the human body.
Viruses, pollen, bacteria, fungi, toxins, mineral particles, soot, and—these days—microplastics permeate
the food we eat and the air we breathe.
To combat this assault, the body uses a diverse tool
kit: the immune system. The body’s response to threats
depends upon its ability to generate an omnifarious
defense, while the microbiome lining the gut surface
contains a complexity that protects and sustains us
in more ways than one. It’s tempting to conclude that
diversity is always a faithful ally.
When a vertebrate immune system faces a new
pathogen, it comes prepared with a variety of weapons.
“The immune system is all about diversity,” said Akiko
Iwasaki, PhD, the Waldemar Von Zedtwitz Professor
of Immunobiology, professor of molecular, cellular,
and developmental biology, and of dermatology, and a
Howard Hughes Medical Institute investigator.
Each young cell of the adaptive immune response
begins life wielding a unique appendage—a single type
of receptor. Each receptor is generated afresh, one per
cell, by genes that recombine and mutate rapidly.
If the pathogen happens to fit a single cell’s receptor—an event analogous to a random key fitting a
lock—the lymphocyte that wields it begins to divide.
Equipped with the correct receptor, all the cell’s progeny can more effectively meet the intruder.
Absent this process, there would be no adaptive
immune response—a “clear example of diversity being
required for survival,” Iwasaki said.
Similarly, at the population level, individual people
muster a variable array of immune responses that limit
the damage that any specific pathogen can do. People
contract infectious diseases all the time, but
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few people are killed by them, save in examples in
which people are immunocompromised or in cases
where the pathogen is extremely deadly.
(Iwasaki has argued that the immunology community itself ought to follow similar principles in its own
ranks, criticizing the ubiquity of homogeneous panels
and speakers at research symposia.)
Then there is the gut microbiome. In recent years,
studies about it have flourished, even as researchers have
come to suspect that this inner ecosystem is growing less
diverse due to restricted diets and antibiotic overprescribing over several decades. This loss of diversity is, it
appears, to our detriment: a higher number of species in
the gut microbiota seems to correlate with better health.
Severe loss of diversity in the gut microbiome can
predispose a person to opportunistic infections. The
classic example is Clostridium difficile infection (CDI),
which can take hold after chronic antibiotic use eradicates ordinary gut residents. As it flourishes, CDI can
cause a life-threatening diarrhea.
“[Antibiotic use can be] like clearing the rainforest
in the gut,” said Noah Palm, PhD ’11, assistant professor of immunobiology. “This weed that was hiding in
the background as spores is able to grow.”
Until recently, physicians treated repeat CDI episodes with antibiotics, a tactic comparable to burning
over the same ground again and again. An alternative
approach: replace the dangerously simple ecosystem
with a diverse one using a fecal microbiota transplant. With cure rates topping 90%, it is now first-line
therapy for third or subsequent nonsevere episodes of
recurrent CDI. This success has inspired researchers to
experiment with fecal microbiota transplantation in a
wide variety of other diseases, including autoimmune
disease, autism, and cancer.

Why did we evolve such a diverse gut community
in the first place? One explanation is that it can shield
us from colonization by pathogens, Palm said. Without
friendly bacteria occupying all available ecological
niches in the gut, a person is profoundly susceptible to
infectious disease.
As an example, to infect a healthy mouse with
Salmonella requires something like 100 million
individual bacteria. But if you dose that mouse with
an antibiotic, thus eradicating part of its gut flora,
it may take only 100 or even 10 Salmonella cells to
cause infection.
“In my opinion, that’s the most important rule
that the microbiota plays evolutionarily,” Palm said.
“Without our microbiota, for that reason alone, all of us
would be dead from pathogenic infection.”
Over deep time, a certain level of gut microbiome
diversity has become necessary for another reason:
nutrition. We’ve lost the ability to synthesize certain
vitamins on our own, instead depending on specific
microbes to perform that metabolic task. The gut
microbiome, too, can unlock complex carbohydrates
whose nutrients would otherwise be out of reach.
On a local level, though, greater diversity isn’t necessarily better. Compared with the gut, for instance,
the vagina prefers a far simpler microbiome. Whether
the lung does best with a wide or narrow range of
organisms remains to be determined.
Andrew Goodman, PhD, the C.N.H. Long Professor
of Microbial Pathogenesis, and director of the Yale
Microbial Sciences Institute, emphasizes the importance of avoiding the reflexive belief that diversity is
invariably beneficial to biological systems.
In clinical care, for example, fecal transplantation
has not fulfilled everyone’s hopes.
“To date, [CDI is] really the only example where there’s
been widespread clinical application of a microbiomebased therapy that’s gone beyond a few isolated trials,”
Goodman said.
Even in the gut, the addition of a new kind of
microbe—ratcheting up the diversity, he points out—is
arguably less healthful if the newcomer is a pathogen.
Palm added that many recent non-CDI fecal transplantation trials have little basis beyond hope on which
to proceed.

“People are throwing darts at a wall without understanding what’s going on” he said. “It’s much less clear
that loss of diversity is actually a cause of disease in
these other, more chronic disorders.”
“The idea of diversity being good, I think, has
caught hold because it’s an attractive idea, and fits
with our concepts also of biodiversity environmentally,” Palm added. “It’ll be interesting … to figure out
in a bit more mechanistic detail when and why it’s
actually good to have diversity, and get beyond some
of these generalizations.”
If fecal transplantation turns out not to be a panacea, what other roles might gut biodiversity play
in clinical care? Goodman, for his part, is studying
the role played by the gut microbiome in the body’s
response to medications. People with the same disease can have different responses to the same drug.
Some of that variability may be explained by differences in the human genome, but the gut microbiome’s
genome, which dwarfs that of its human host, may
also be involved.
Goodman points out that researchers have identified gut microbes that metabolize two-thirds of the
medications they’ve examined. How those metabolites
affect the host is still unknown, he said, “but at least
the potential is there. We’re just starting to understand
the rules.”
“I’ve always been interested in the molecular mechanisms of gut microbial ecology. We have a lot more
to learn,” Goodman said. “It’s a very fun time and a
very exciting time to be in the field.” /yale medicine
magazine
Jenny Blair is a frequent contributor to Yale Medicine Magazine.
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		 A bottle
for baby
			 Many know of YSM’s renowned collection of medical curiosities.
Few, however, know of a unique collection: antique baby bottles.
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Among the noteworthy collections at Yale
is Yale New Haven
Hospital’s collection
of baby bottles, which
includes extraordinary examples from
across a broad scope
of cultures and human
history dating back
to ancient Rome. As
is often the case, the
collection was the
result of one doctor’s
curiosity and interest
in the subject.
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		 Learning across
boundaries to
			 end preventable
		 maternal deaths
every two minutes, a woman dies from pregnancyor childbirth-related complications. Mary-Ann Etiebet,
MD/MBA ’03, wants to change that. In 2016, Etiebet joined
Merck to be the executive director of Merck for Mothers,
a global initiative focused on ending preventable maternal
deaths. She uses her background in medicine and business
to advance innovative multisectoral approaches to reducing
maternal mortality around the world.
Etiebet, who grew up in Nigeria,
always knew she was going to
become involved in health care—
she just didn’t know how. She
decided to pursue medicine when
on a drive to school one day, she
spotted a teenage girl with rickets walking down the road with
her younger brother. The brother
wore a school uniform, but the
young girl did not, and could no
longer pursue her education.
“I realized that without good
health you couldn’t realize your
full potential, or completely have
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economic independence,” Etiebet
said. “Even now, that moment is a
reminder that we cannot separate
the effects of health from broader
societal opportunities.”
Etiebet pursued her higher
education in the United States,
studying political science as an
undergraduate at Yale before
continuing on to the MD/MBA

program. She realized that to
effect the kind of institutional
changes and sustainable health
care outcomes she envisioned,
she would need to understand
medicine, society, business, and
policy—and that Yale was the
perfect place to do all of that.
“The whole ethos of the University, and the cross-disciplinary
learning that happens between
the schools and the departments,
meant there was enough flexibility in the curriculum to be
able to prepare myself for those
non-traditional paths,” she said.
After graduation Etiebet
completed her internal medicine
residency at Cornell, infectious
disease fellowship at Columbia,
and then joined the faculty at
the University of Maryland,
where she worked on their
PEPFAR HIV/AIDS program
in Nigeria. During her time
there, she contributed to health
care policy and health systemstrengthening efforts, and saw
firsthand the positive effects of
integrating the clinical public
health and public policy arenas.
Merck for Mothers offered
Etiebet the perfect opportunity to put to use skills she
had accrued over the years. “It
brought together my international experience, my U.S.based experience, and the
research I’d done,” she said.
“More importantly, it allowed me
to think about how to harness
the role of the private sector to
advance innovation and bring
diverse stakeholders to this
issue—space.”
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At Merck, Etiebet manages a
core team of 12 people, access to
experts across the Merck enterprise with whom she can consult with for different projects.
Merck for Mothers currently has
active projects in 48 countries,
with a focus on four countries
with high rates of preventable
maternal deaths: Nigeria, India,
Kenya, and the United States.
It often surprises people that
maternal mortality is on the rise
in the U.S., Etiebet said, particularly since global rates are declining. For many years, the U.S. did
not closely track its number of
preventable deaths, and thus
researchers did not understand
why women were dying during
pregnancy and childbirth. Data
collected by the CDC through the
support of Merck for Mothers
found that over 60% of maternal
deaths for American women
are preventable.
“Once data became available,
we saw that our rates are actually
getting worse, not better, and
we’re seeing increased disparities between Black and White
women,” Etiebet said.
Black women are, on average, three to four times more
likely to die from maternal complications than White women.
Maternal mortality rates highlight some of the institutionalized inequities in the U.S.,
Etiebet said.
That’s why in 2018, Merck
for Mothers launched the Safer
Childbirth Cities Initiative,
which aims to support community-based organizations in

In her role at Merck for
Mothers, Mary-Ann
Etiebet leads active
projects in 48 countries
to help reduce the rate
of preventable maternal deaths.

cities across the U.S. with a high
burden of maternal mortality
and morbidity by implementing
local solutions that bridge the
gap between clinic and community, which helps cities become
safer—and more equitable—
places to give birth.
Additionally, by supporting organizations like the CDC
and the Association of Maternal
& Child Health Programs
(AMCHP), Merck for Mothers
has helped increase the number
of states with official maternal
death review committees to
more than 40. And most importantly, Etiebet said, these states
have incorporated patients’

voices into those committees, to
make sure health care providers understand what happens to
women before they walk into a
hospital to deliver.
“To reduce preventable maternal deaths, health equity needs to
be put front and center, and we
believe that all the solutions that
are developed and implemented
should not just be informed by,
but led by the women that are
impacted,” Etiebet said. At the
international level, Etiebet and
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Ilkay Alp Yıldırım, PhD,
an associate professor of pharmacology
at Istanbul University,
learned many key practices and research habits during a postgraduate fellowship at Yale
School of Medicine.
For more on Yıldırım, visit
ymm.yale.edu/pharma

her team work to make sure that
the interventions they bring to
different countries are sustainable.
“We think about the local
ecosystem, and who will continue to champion and invest in
this work,” Etiebet said. “We
ask, ‘How can we use the local
private sector to continue to
advance progress?’ ”
A good example is a platform
called Together for Her Health,
which creates an online rating
system for women in communities
in India to review their maternal
health care providers. The system
not only informs other women
about the best clinics to seek for
different services, Etiebet said, it
also creates an incentive for other
facilities to improve their offerings
so that they don’t lose patients.
“Sustainability is enabled
when we create value,” Etiebet
said. “If we listen to and value
women and their experiences,
we can reduce the number of
maternal deaths.”
—Riley Davis

»

Bringing it full circle

The UCLA School of Law faculty biography page for Julie D.
Cantor, JD, MD ’05, describes
her as “a national expert on
issues that fall at the intersection of medicine and law.” It’s
clear that Cantor, as a professor, attorney, physician, artist,
entrepreneur, and mother, operates at many intersections.
Her rich diversity of passions and interests began in
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childhood. “I came from a family that valued both education
and entrepreneurship,” Cantor
said. “And always trying to
contribute in a unique and necessary way.” Even at a young
age, she understood the need
for social justice and advocacy.
When a busy street near her
childhood home needed a crossing guard, Cantor said, “I was
so incensed about that problem
that as a 6-year-old, I wrote a
letter to the editor of the local
newspaper about it.”
Cantor was raised on action.
In the 1970s, her father, a children’s dentist and artist, and her
mother, a kindergarten teacher,
created a space-themed children’s dental practice. It was
complete with spaceship decor
and pilot uniforms. “I think they
had an innate sense that what it
takes to succeed in this culture is
to do something that’s different,
that’s creative,” Cantor said.
She quickly discovered both
aptitude and enthusiasm for
school, which eventually led to
Stanford University. Majoring
in psychology, she also engaged
with history, literature, and art
history—and took advantage of
an opportunity to study in Italy,
where her mother had studied
and where her parents honeymooned. The country had a lasting effect on Cantor.
After completing both a
BA and an MA in psychology,
Cantor worked at the Program
in Bioethics at UCSF. There, she
worked with a physician and
an attorney. “I liked the way

[they] would comment on things
that were going on in the world
at the intersection of law and
medicine,” she said. Her mentors wrote about the potential
impact of cases pending before
the Supreme Court of the United
States on assisted suicide, and
the piece was published in a
leading medical journal. “I
remember thinking: that’s the
pinnacle of greatness,” Cantor
said. “How do I get to do that?”
Cantor spent two years at the
University of California, Berkeley,
School of Law, then moved to Yale
to complete a visiting year at Yale
Law School and begin medical
school. Yale School of Medicine
proved an opportunity for Cantor
to explore, refine, and coalesce
her interests. She enjoyed writing
and lecturing, and published her
first article in the New England
Journal of Medicine. Though her
passions did not fit neatly, Cantor
said, “I just kept pursuing things
that were interesting to me and
had hoped—and continue to
hope—I can contribute to other
people’s lives and contribute to
the dialogue.”
After graduating, Cantor
accepted a position with a Los
Angeles law firm, Munger, Tolles
& Olson LLP. She was one of a
handful of physicians in her Yale
class to pursue an option other
than residency. “It was a very
academic firm, so I knew they
would be okay with me wanting to teach and lecture,” she
said. While juggling work as
an adjunct professor at UCLA
School of Law and also starting
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a family, she made a name for
herself at the firm working on
cases informed by her medical
background, including a case
challenging Kentucky’s lethal
injection protocol, for which
she co-authored an amicus brief
to the U.S. Supreme Court.
“I was really fortunate to work
on teams with people who were
so illustrious in their field as
lawyers that they brought in
these incredibly interesting
cases,” she said.
Cantor’s next career endeavor
grew, as always, from an eye
attuned to progress. Working
as a litigator and representing
high-profile clients, she found
herself saddled with an unwieldy
amount of paperwork, baggage,
and materials. “I had a rolling
bag, a tote, plus a laptop,” she
said. “When you add it all up
it’s pretty heavy, and I thought
there’s got to be a way where
this can really have an element
of self-expression and style, and
also be beautifully made and
made to last forever, and can be
totally functional.”
As she had when she was 6
years old, Cantor recognized and
addressed a need. To create a
perfect career accessory, Cantor
founded Harlen, a brand that
elevates women’s work bags to
Modern Careerpieces, a term she
trademarked. Harkening back to
her time—as well as her mother’s
time—studying art history in
Italy, the Harlen Collection is
handcrafted in Italy. She named
the brand for her grandparents,
Harriet and Lenny, whom she

Yale School of
Medicine alumna Julie
Cantor demonstrates
that an MD can
lead far outside the
physician’s field. She
has co-authored an
amicus brief to the Supreme Court, founded
the Harlan Collection,
and published in The
New England Journal
of Medicine.

credits with igniting her sense
a sophomore seminar; and by
of style and who were also “real
writing about issues that affect
supporters of girls’ education and both of those fields. And she’s
empowerment and autonomy
frequently approached with
and independence.” In that spirit, requests for public comment.
to move opportunity from sucWhether in the New England
cessful women to the next genJournal of Medicine or on Good
eration, Harlen partners with
Morning America or somewhere
Room to Read, an acclaimed
in between, Cantor is always
non-governmental organization
happy to speak. As she puts it,
dedicated to global literacy and
“it’s an opportunity to take what
girls’ education.
I’ve learned, including what I
Though many things have
learned at Yale, and advance the
come full circle for Cantor, she
conversation, improve lives, and
isn’t finished. In addition to
solve problems.”
leading Harlen, she remains
—Lauren Kay Johnson
engaged with both medicine
and law through her UCLA
Law seminar, “Reproductive
Rights, Medical Ethics & the
Law,” which began at Yale as
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question and answer

than the boys.” I didn’t
personally know any doctors growing up. And the
impact of one encouraging me to pursue that

			 When the bone breaks,
		 the cradle won’t fall
LISA LATTANZA, MD,

credits strong mentorship and an unusual

career path with her resounding success in the field of ortho-

goal, acting as a mentor
and role model—that
was so important. The
Perry Initiative is held in
54 locations nationwide
now, offering daylong
programs for young
women in high school
who want to explore

paedic surgery. She’s excited to bring the lessons she’s learned

opportunities in science,

to the Yale Department of Orthopaedics and Rehabilitation.

and orthopaedic surgery.

There are three female chairs of medical school orthopae-

We also have a Medical

dics departments in the United States. The most recent, Lisa

for first- and second-year

Lattanza, MD, comes to Yale School of Medicine via the
University of California San Francisco.

specifically engineering

School Outreach Program
female medical students
to expose them to the
specialty; as an overall
field, the national aver-

Your journey to department

therapy, and the latter

medicine. She would

age for women applying

chair has been unusual.

seemed like a feasible way

always listen to everyone

and being accepted into

How did growing up lead

to enter the profession,

in the room, regardless of

an orthopaedics program

you to the field of medicine?

so that’s what I studied

hierarchy. … She encour-

is 14%. For first- and

I come from a family of

in undergrad. I landed

aged me to attend medical

second-year women who

five kids in rural Ohio.

a job at the Kerlan-Jobe

school, and was generally

have gone through our

My mother was a teacher

Orthopaedic Center in Los

a huge advocate of women

program, it’s 26-30%.

and my dad was a school

Angeles, where I treated

in medicine. Being a doc-

psychologist. I had always

patients with sports inju-

tor had always seemed

thought about a career in

ries and did research. I

impractical and then

physical therapist as a dis-

medicine but they told

also met a prominent

I worried that maybe I

traction, then? Quite the

me they couldn’t afford

orthopaedic surgeon,

wasn’t smart enough—I’m

contrary. I wouldn’t be

medical school. A high

Jacquelin Perry, MD.

old enough to remember

the surgeon I am without

being told by an elemen-

that practical whole-

Is that the Perry of your

tary school teacher, “You

person approach that I

Perry Initiative? That’s

don’t want to be smarter

learned as a physical ther-

school sports injury
exposed me to orthopaedic surgery and physical

{ To nominate a subject for Q&A, contact

right. Perry had an enor-

apist. Surgeons can fall

mous impact on how I

into the trap of viewing

viewed the practice of

the body mechanistically,
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Do you view your time as a

Q&A WITH

Lisa
Lattanza
like, a part here breaks

printing organs, using

and you fix it. And while

material grown from a

there’s some truth to there

patient’s own cells for

being a kind of inter-

transplant. What I would

changeability of some

like to see happen on this

parts, they all affect each

and make them a thumb

campus is a 3D surgical
center that’s multidis-

other, and you really see

from an index finger or

that with certain injuries

toe. And, boom, their life

ciplinary. … Radiology,

that cause a cascade of

was impacted forever in

general surgery, ortho-

secondary and tertiary

a positive way. Prior to

paedics, maxillofacial,

problems. All surgeons

that experience my dream

plastic surgery, urology,

don’t need to take the

job had been team physi-

whoever can benefit from

path I did, but I appreciate

cian for the Pittsburgh

this technology. That will

the road I traveled.

Steelers (my dad had

keep Yale at the forefront

grown up there), but see-

of surgical innovation and

When did you realize you

ing the impact that kind

treatment.

wanted to be an orthopaedic

of surgery had versus an

surgeon specifically?

ACL reconstruction so

an expansion of our

The seed was planted at

that someone could go

capabilities regionally

Kerlan-Jobe, a big sports

back to playing a sport. …

and internationally. We

medicine group that took

and now I’m a hand and

can always add to the

care of the Lakers and

upper extremity surgeon

great job we’ve done sup-

Dodgers among other pro-

treating both children and

porting the local com-

fessional athletes.

adults. My time at Texas

munity’s orthopaedic

I’d lettered in three

Scottish Rite Hospital for

needs. There are also

sports in high school,

Children in Dallas with

plans to continue build-

played basketball, ran

Marybeth Ezaki, MD, and

ing on existing global

cross country in college,

Peter Carter, MD, also

partnerships. Those take

and had a passion for ath-

helped play a role in that

the shape of clinical

letic competition.

decision; I really have

growth, and also volun-

I went back to medi-

been blessed with fantas-

teer projects.

cal school to become an

tic mentors.

orthopaedic surgeon.
I initially thought during

CONDUCTED BY

Adrian
Bonenberger

Other plans include

Finally, I hope to keep
our departmental eye on

What are your plans for the

the ball when it comes

residency that I would

department, moving for-

to diversity, equity, and

pursue sports medicine

ward? Right now, ortho-

inclusion. A lot of people

specialty training but

paedic surgery benefits

who grew up thinking

that changed when I did

tremendously from 3D

they couldn’t make it or

a couple of congenital

printing for planning—

ortho wasn’t for them

hand cases with a hand

where to cut a bone, how

when I was younger have

surgeon at the children’s

to resolve complicated

done a good job of open-

hospital in Kansas City. It

procedures—this increases

ing locked doors. We’re

blew my mind that you

the effectiveness of opera-

all hoping to see the next

could take a child that

tions and reduces error.

generation walk through.

was born without a thumb

In the future, though, it
looks like we’re headed
toward 3D-printed bio-

R O B E R T A . L I S A K P H OTO S

materials. Printing bones,
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book review

		 How to make the lives
of those with dementia joyful
By Cathy Shufro
Psychiatrist and bioethi-

tolerable but even joyful.

metaphor). Yet medicine is

diapers, older individuals

cist Tia Powell, MD ’87, has

Powell reminds readers that

embarrassed to admit this.

lost after wandering away

already written her demen-

the burden of Alzheimer’s

Care seems soft and unscien-

from caregivers. She rejects
the claim that the costs of

tia playlist just in case. The

and other forms of dementia

tific; we’d prefer to hand out

list comprises 16 songs she

will only worsen as she and

[a] swashbuckling cure.”

loves, beginning with “Let’s

her fellow baby boomers

Groove” by Earth, Wind &

grow older. Dementia affects

improve care by looking

Fire, and wrapping up with

roughly four out of 10 people

beyond the immediate effects

benefit from working together.

Otis Redding’s version of

who reach age 85. However,

of a potential treatment or

In some places in Europe,

“Try a Little Tenderness” and

she writes, “This illness is not

test. For instance, perhaps the

for example, young artists and

the Billie Holiday rendition

just about loss; it is also about

$2,500 for a PET scan would be

musicians get free or reduced

of “I’ll Be Seeing You.”

preservation—of affection, of

better spent helping a patient

housing in return for helping

dignity, of hope.”

arrange help with meals

older people who live along-

(nutrition) or avoid isolation

side them.

Those tunes could come
in handy if Powell develops

Powell fears that no pill

She said physicians can

and younger individuals can

Powell believes that our

will arrive to save her gener-

by joining a singing group

who can no longer speak

ation; present experimental

(possibly improving mood

often still enjoy music. “This

drugs for Alzheimer’s, for

and mental status). To add this

“I love to think I’m smart, but

playlist helps me create

instance, have a 99.6% failure

layer of care, medical practices

I’m not sure that snobbery is

a positive image of living

rate. “Science plays the long

could employ a social worker

one of my best features. There

with dementia,” said Powell,

game,” she said. And so while

or treatment coordinator. “The

has been some very interesting

who directs the Montefiore

scientists work toward a cure,

benefit of being part of Big

thinking by people in the dis-

Einstein Center for Bioethics

Powell recommends that we

Medicine is you may be able to

ability rights movement about

access resources that a single

what defines a person, and to

dementia, as even people

society overvalues intelligence.

and holds the Shoshanah

also invest in care. “If we

Trachtenberg Frackman

focused more on the reality of

doc in a lone office is not able

what sort of person we owe

Chair in Bioethics at Albert

care and less on the fantasy

to,” Powell said.

respect and consideration.

Einstein College of Medicine.

of eradication, we might deal

In Dementia Reimagined:
Building a Life of Joy and

with these pressing issues.”
For physicians, this

Powell manages to remain

“I find it very upset-

upbeat, peppering her book

ting when people talk about

with witticisms while also

having dementia as being

Dignity from Beginning to

approach will require a cul-

addressing the challenges

a loss of dignity,” she said.

End, Powell explores how

tural shift. Medicine “sees

of dementia, from the huge

Drooling and incontinence

technology, intergenerational

itself as manly, offering

expense (“heading like a me-

are “adorable in babies, and

heroic cures,” Powell wrote.

teor toward the children of

accepted as a natural part of

the baby-boom generation”)

the developmental arc.” In

symbiosis, and shifts in
values can make the lives of
those affected not only more

{ Send notices of new books to

“But a great deal of what
medicine offers patients is

to the nitty-gritty: adults in

older people, “that’s just the

care—incremental, accom-

body breaking down, not a

modating, feminine (if you

moral failure. It’s an arc, and

stick with the outmoded

it goes back down again.”
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dementia care will spark an
intergenerational war. Older

O P P O S I T E : H A R O L D S H A P I R O P H OTO

			

end note

Changing of the guard
F RO M A D I V E R S I T Y P E R S P E C T I V E ,

the future is now when it comes to the student body of the

School of Medicine. At Yale’s White Coat Ceremony on August 12, it was impossible not to witness
progress in a class that is anything but homogeneous as members of the Class of 2023 pulled on their
symbolic white coats.
Beyond the superficial differences among students, the class included 32 future physicians born
in 15 countries outside the United States, and from disparate economic and academic backgrounds
(including 29 students from groups underrepresented in medicine, or URiM, over a quarter of the
class). Fifteen students were the first in their family to attend college.
Emily Wang, MD, associate professor of medicine (general medicine) and director of the Health
Justice Lab, delivered the keynote address. She instructed her audience to think about the roles they
can play in their patients’ lives. “Starting today, your white coat gives you the privilege to bear witness to your patients’ sufferings and their strengths; to share that burden, and then to safeguard
their human civil rights.”
—Adrian Bonenberger
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